Amy Gibson MPS[/caption]
Symptoms
COVID-19: Finish line or first lap?
As Australia reaches vaccine targets, what’s next for pharmacists and Australians?
Why you should read PSA’s new medicine management guidelines
At PSA22, new guidelines were launched to help pharmacists support Aboriginal and Torres Strait Islander peoples with Medicines Management.
Glauber’s salt: the laxative of choice until the 1900s
Until ‘more sophisticated alternatives’ came about in the 1900s, Glauber’s salt was the global go-to purgative.
The aged care researcher
The expert witness testimony of Dr Janet Sluggett MPS at the aged care royal commission last year resulted in changes to the RMMR program.
COVID-19 healthcare leader moves into new role
Deputy Chief Medical Officer Professor Michael Kidd AO reflects on steering Australia through the COVID-19 pandemic and his next career move.
High-dose antipsychotic therapy: does it have a role?
A high proportion of people prescribed antipsychotic polypharmacy are also taking high-dose antipsychotic therapy.
